The Ras switch in structural and historical perspective
- PMID: 31600136
- DOI: 10.1515/hsz-2019-0330
The Ras switch in structural and historical perspective
Abstract
Since its discovery as an oncogene more than 40 years ago, Ras has been and still is in the focus of many academic and pharmaceutical labs around the world. A huge amount of work has accumulated on its biology. However, many questions about the role of the different Ras isoforms in health and disease still exist and a full understanding will require more intensive work in the future. Here we try to survey some of the structural findings in a historical perspective and how it has influenced our understanding of structure-function and mechanistic relationships of Ras and its interactions. The structures show that Ras is a stable molecular machine that uses the dynamics of its switch regions for the interaction with all regulators and effectors. This conformational flexibility has been used to create small molecule drug candidates against this important oncoprotein.
Keywords: GAP; GEF; Ras; effector; switch regions.
References
-
- Ahearn, I.M., Haigis, K., Bar-Sagi, D., and Philips, M.R. (2011). Regulating the regulator: posttranslational modification of RAS. Nat. Rev. Mol. Cell. Biol. 13, 39–51.
-
- Ahmadian, M.R., Stege, P., Scheffzek, K., and Wittinghofer, A. (1997). Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat. Struct. Biol. 4, 686–689.
-
- Aoki, Y., Niihori, T., Kawame, H., Kurosawa, K., and Ohashi, H. (2005). Germline mutations in HRAS protooncogene cause Costello syndrome. Nat. Genet. 37, 1038–1040.
-
- Bandaru, P., Shah, N.H., Neel, H., Bhattacharyya, M., Barton, J.P., Kondo, Y., Cofsky, J.C., Gee, C.L., Chakraborty, A.K., Kortemme, T., et al. (2017). Deconstruction of the Ras switching cycle through saturation mutagenesis. eLife 6, e27810.
-
- Bery, N., Cruz-Migoni, A., Bataille, C.J.R., Quevedo, C.E., Tulmin, H., Miller, A., Russell, A., Phillips, S.E., Carr, S.B., and Rabbitts, T.H. (2018). BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions. eLIFE 7, e37122.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous